ArticleCancer research communications2022

Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.

Xin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.